Evaluation of Morphofunctional and Baropodometric Changes in Pregnant Women
Launched by UNIVERSITY OF SEVILLE · Nov 17, 2024
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how pregnancy affects the feet and ankles of women. During pregnancy, women experience changes in their bodies, like weight gain and hormonal shifts, which can lead to differences in how their feet function. The researchers want to understand these changes better, especially how they develop before, during, and after pregnancy. By studying these aspects, they hope to help prevent and manage foot problems that pregnant women might face.
To participate in this trial, women need to be healthy, between the ages of 20 and 35, and if they are pregnant, they should be in their first trimester (less than 12 weeks along). They should not have any serious health issues that could affect their feet or have had any previous surgeries on their feet or ankles. Women with multiple pregnancies or certain foot conditions will not be eligible. Participants can expect to undergo assessments that will help the researchers gather information on how pregnancy impacts foot health, contributing to better care for future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy women between 20 and 35 years old.
- • 2. If pregnant, they must be in the first trimester of pregnancy (before week 12).
- • 3. Absence of chronic or acute pathologies that may interfere with the analysis of biomechanical variables (arthritis, vascular or metabolic problems).
- • 4. Not having had previous foot or ankle surgeries.
- Exclusion Criteria:
- • 1. Women with multiple pregnancies (twin or multiple pregnancies increase biomechanical variations).
- • 2. Conditions that affect gait or foot structure (arthritis, neuropathies, or other orthopedic problems).
- • 3. History of previous foot or ankle injuries that may alter measurements.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, , Spain
Sevilla, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported